Log in
Sign up
Golden has been acquired by ComplyAdvantage.Read about it here ⟶
‌

US Patent 10064801 RNA complexes that inhibit melanin production

Patent 10064801 was granted and assigned to OliX Pharmaceuticals on September, 2018 by the United States Patent and Trademark Office.

OverviewStructured DataIssuesContributorsActivity
Is a
Patent
Patent
0
Current Assignee
OliX Pharmaceuticals
OliX Pharmaceuticals
0
Date Filed
July 27, 2016
0
Date of Patent
September 4, 2018
0
Patent Applicant
OliX Pharmaceuticals
OliX Pharmaceuticals
0
Patent Application Number
15220767
0
Patent Citations Received
‌
US Patent 10829761 Treatment of idiopathic pulmonary fibrosis using RNA complexes that target connective tissue growth factor
‌
US Patent 10947541 Treatment of atopic dermatitis and asthma using RNA complexes that target IL4Rα, TRPA1, or F2RL1
‌
US Patent 10883105 RNA-interference-inducing nucleic acid molecule able to penetrate into cells, and use therefor
‌
US Patent 11591600 Long double-stranded RNA for RNA interference
‌
US Patent 11040057 Pharmaceutical compositions and methods for potentiating gene silencing
‌
US Patent 10519449 Treatment of angiogenesis-associated diseases using RNA complexes that target ANGPT2 and PDGFB
‌
US Patent 10590423 Treatment of age-related macular degeneration using RNA complexes that target MyD88 or TLR3
‌
US Patent 10829760 Nucleic acid molecules inducing RNA interference, and uses thereof
Patent Inventor Names
Sun Woo Hong
0
Isu Hong
0
Ji Hyun Kim
0
Patent Jurisdiction
United States Patent and Trademark Office
United States Patent and Trademark Office
0
Patent Number
10064801
0
Patent Primary Examiner
‌
Tracy Vivlemore
0

Find more entities like US Patent 10064801 RNA complexes that inhibit melanin production

Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
Open Query Tool
Access by API
Golden Query Tool
Golden logo